Official Title
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Brief Summary

The goal of this pilot clinical trial is to determine feasibility and explore whetherfinancial incentives paid to primary care patients for completing colorectal cancerscreening increase completion of colorectal cancer screening. The main questions it aimsto answer are: - Do patient financial incentives for completing colorectal cancer screening increase screening completion? - Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?Participants who are due for colorectal cancer screening will receive telephone outreachfrom primary care staff who will offer a stool-based colorectal cancer screening.Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participantswill be offered financial incentives for completing COVID-19 and flu shots within 2months of enrollment. Group 2 participants will be offered financial incentives forcompleting a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 monthsof enrollment.Researchers will compare to see if completion of a COVID-19 shot, a flu shot, andcolorectal cancer screening is different between the two groups.

Detailed Description

Not Provided

Completed
Health Behavior
Colorectal Cancer
Influenza
COVID-19
Vaccine Hesitancy
Vaccine-Preventable Diseases
Healthcare Patient Acceptance

Behavioral: Financial incentive for colorectal cancer screening

$50 incentive paid to participant for completion of colorectal cancer screening within 2
months of enrollment

Behavioral: Financial incentive for flu shot

$50 incentive paid to participant for completion of flu shot within 2 months of
enrollment

Behavioral: Financial incentive for COVID-19 shot

$50 incentive paid to participant for completion of COVID-19 shot within 2 months of
enrollment

Eligibility Criteria

Inclusion Criteria:

- Age 45 to 75

- Receive care at participating primary care clinic

- Due for colorectal cancer screening

- Ability to understand and speak English

Exclusion Criteria:

- Currently participating in another clinical trial or research study on colorectal
cancer screening

- Unable or unwilling to give informed consent

Eligibility Gender
All
Eligibility Age
Minimum: 45 Years ~ Maximum: 75 Years
Countries
United States
Locations

Tulane University School of Medicine
New Orleans 4335045, Louisiana 4331987, United States

Marie A Krousel-Wood, MD, MSPH, Principal Investigator
Tulane University

National Heart, Lung, and Blood Institute (NHLBI)
NCT Number
Keywords
Cancer screening
Preventive healthcare
Vaccine Uptake
Patient financial incentives
Federally qualified health center
Health services
MeSH Terms
Health Behavior
Colorectal Neoplasms
Influenza, Human
COVID-19
Vaccination Hesitancy
Vaccine-Preventable Diseases
Patient Acceptance of Health Care
Influenza Vaccines